{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:05:47Z","timestamp":1789020347454,"version":"build-2803163510"},"reference-count":172,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education, Science and Technological Development, Republic of Serbia","award":["451-03-68\/2022-14\/200161"],"award-info":[{"award-number":["451-03-68\/2022-14\/200161"]}]},{"name":"University of Belgrade Faculty of Pharmacy","award":["451-03-68\/2022-14\/200161"],"award-info":[{"award-number":["451-03-68\/2022-14\/200161"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Dry eye syndrome and allergic conjunctivitis are the most common inflammatory disorders of the eye surface. Although eye drops are the most usual prescribed dosage form, they are characterized by low ocular availability due to numerous barrier mechanisms of the eye. The use of biopolymers in liquid ophthalmic preparations has numerous advantages, such as increasing the viscosity of the tear film, exhibiting bioadhesive properties, and resisting the drainage system, leading to prolonged retention of the preparation at the site of application, and improvement of the therapeutic effect. Some mucoadhesive polymers are multifunctional excipients, so they act by different mechanisms on increasing the permeability of the cornea. Additionally, many hydrophilic biopolymers can also represent the active substances in artificial tear preparations, due to their lubrication and moisturizing effect. With the modification of conventional ophthalmic preparations, there is a need for development of new methods for their characterization. Numerous methods for the assessment of mucoadhesiveness have been suggested by the literature. This review gives an overview related to the development of mucoadhesive liquid ophthalmic formulations for the treatment of dry eye and allergic conditions.<\/jats:p>","DOI":"10.3390\/pharmaceutics15020470","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T04:27:02Z","timestamp":1675225622000},"page":"470","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Biopolymers in Mucoadhesive Eye Drops for Treatment of Dry Eye and Allergic Conditions: Application and Perspectives"],"prefix":"10.3390","volume":"15","author":[{"given":"An\u0111elka","family":"Ra\u010di\u0107","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Banja Luka-Faculty of Medicine, Save Mrkalja 14, 78000 Banja Luka, Bosnia and Herzegovina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danina","family":"Kraji\u0161nik","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology and Cosmetology, University of Belgrade-Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Addo, R.T. (2016). Ocular Drug Delivery: Advances, Challenges and Applications, Springer.","DOI":"10.1007\/978-3-319-47691-9"},{"key":"ref_2","unstructured":"Bouwman-Boer, Y., Fenton-May, V., and Le Brun, P. (2015). An international Guideline for the Preparation, Care and Use of Medicinal Products, Springer."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Dubald, M., Bourgeois, S., Andrieu, V., and Fessi, H. (2018). Ophthalmic drug delivery systems for antibiotherapy\u2014A review. Pharmaceutics, 10.","DOI":"10.3390\/pharmaceutics10010010"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1208\/s12249-021-01977-0","article-title":"Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations","volume":"22","author":"Lanier","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/03639040802713460","article-title":"Selected polysaccharides at comparison for their mucoadhesiveness and effect on precorneal residence of different drugs in the rabbit model","volume":"35","author":"Zambito","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"102342","DOI":"10.1016\/j.cis.2020.102342","article-title":"Strategies to prolong the residence time of drug delivery systems on ocular surface","volume":"288","author":"Grassiri","year":"2020","journal-title":"Adv. Colloid Interface Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","article-title":"The use of mucoadhesive polymers in ocular drug delivery","volume":"57","author":"Ludwig","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.4155\/tde.12.94","article-title":"Drug delivery to the eye: Current trends and future perspectives","volume":"3","year":"2012","journal-title":"Ther. Deliv."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Galloway, N.R., Amoaku, W.M., Galloway, P.H., and Browning, A.C. (2022). Common Eye Diseases and Their Management, Springer.","DOI":"10.1007\/978-3-031-08450-8"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bye, L., Modi, N., and Stanford, M. (2013). Basic Sciences for Ophthalmology, OUP Oxford.","DOI":"10.1093\/med\/9780199584994.001.0001"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Frutos-Rincon, L., Gomez-Sanchez, J.A., Inigo-Portugues, A., Acosta, M.C., and Gallar, J. (2022). An Experimental Model of Neuro-Immune Interactions in the Eye: Corneal Sensory Nerves and Resident Dendritic Cells. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23062997"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.clae.2021.02.009","article-title":"BCLA CLEAR-Anatomy and physiology of the anterior eye","volume":"44","author":"Downie","year":"2021","journal-title":"Contact Lens Anterior Eye"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pathak, Y., Sutariya, V., and Hirani, A.A. (2016). Nano-Biomaterials for Ophthalmic Drug Delivery, Springer.","DOI":"10.1007\/978-3-319-29346-2"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","article-title":"Anatomy of cornea and ocular surface","volume":"66","author":"Sridhar","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Addo, E., Bamiro, O.A., and Siwale, R. (2016). Ocular Drug Delivery: Advances, Challenges and Applications, Springer.","DOI":"10.1007\/978-3-319-47691-9"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Pathak, Y., Sutariya, V., and Hirani, A.A. (2016). Nano-Biomaterials for Ophthalmic Drug Delivery, Springer.","DOI":"10.1007\/978-3-319-29346-2"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Irimia, T., Ghica, M.V., Popa, L., Anuta, V., Arsene, A.L., and Dinu-Pirvu, C.E. (2018). Strategies for Improving Ocular Drug Bioavailability and Corneal Wound Healing with Chitosan-Based Delivery Systems. Polymers, 10.","DOI":"10.3390\/polym10111221"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"120924","DOI":"10.1016\/j.ijpharm.2021.120924","article-title":"Drug delivery to the anterior segment of the eye: A review of current and future treatment strategies","volume":"607","author":"Mofidfar","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_19","unstructured":"Gibson, M. (2009). Pharmaceutical Preformulation and Formulation, CRC Press. [2nd ed.]. Volume Ophthalmic Dosage Forms."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jtos.2017.03.006","article-title":"TFOS DEWS II Tear Film Report","volume":"15","author":"Willcox","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Rahman, M.M., Kim, D.H., Park, C.K., and Kim, Y.H. (2021). Experimental Models, Induction Protocols, and Measured Parameters in Dry Eye Disease: Focusing on Practical Implications for Experimental Research. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212102"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.exer.2013.08.010","article-title":"Tear film stability: A review","volume":"117","author":"Sweeney","year":"2013","journal-title":"Exp. Eye Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.survophthal.2003.12.009","article-title":"Determinants of eye drop size","volume":"49","author":"Ludwig","year":"2004","journal-title":"Surv. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry eye disease: An immune-mediated ocular surface disorder","volume":"130","author":"Stevenson","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1471-4922(03)00122-3","article-title":"Mucin and Toll-like receptors in host defense against intestinal parasites","volume":"19","author":"Moncada","year":"2003","journal-title":"Trends Parasitol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.preteyeres.2018.11.007","article-title":"Reconsidering the central role of mucins in dry eye and ocular surface diseases","volume":"71","author":"Baudouin","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1900194","DOI":"10.1002\/mabi.201900194","article-title":"Progress and Current Trends in the Synthesis of Novel Polymers with Enhanced Mucoadhesive Properties","volume":"19","author":"Brannigan","year":"2019","journal-title":"Macromol. Biosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1517\/14712598.2.3.287","article-title":"Developments in the area of bioadhesive drug delivery systems","volume":"2","author":"Lehr","year":"2002","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"120429","DOI":"10.1016\/j.carbpol.2022.120429","article-title":"Mucoadhesive chitosan-and cellulose derivative-based nanofiber-on-foam-on-film system for non-invasive peptide delivery","volume":"303","author":"Stie","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Alcantara, K.P., Nalinratana, N., Chutiwitoonchai, N., Castillo, A.L., Banlunara, W., Vajragupta, O., Rojsitthisak, P., and Rojsitthisak, P. (2022). Enhanced Nasal Deposition and Anti-Coronavirus Effect of Favipiravir-Loaded Mucoadhesive Chitosan\u2013Alginate Nanoparticles. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14122680"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1016\/j.ijbiomac.2022.10.058","article-title":"Chitosan\/HPMC-based mucoadhesive film co-loaded with fluconazole and ofloxacin for management of polymicrobial keratitis","volume":"222","author":"Sanap","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Syed, M.A., Aziz, G., Jehangir, M.B., Tabish, T.A., Zahoor, A.F., Khalid, S.H., Khan, I.U., Hosny, K.M., Rizg, W.Y., and Hanif, S. (2022). Evaluating Novel Agarose-Based Buccal Gels Scaffold: Mucoadhesive and Pharmacokinetic Profiling in Healthy Volunteers. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081592"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijbiomac.2017.11.170","article-title":"Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: In-vitro characterization, ocular tolerance and antibacterial activity","volume":"108","author":"Ameeduzzafar","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/1061186X.2020.1871483","article-title":"Lipo-PEG nano-ocular formulation successfully encapsulates hydrophilic fluconazole and traverses corneal and non-corneal path to reach posterior eye segment","volume":"29","author":"Kakkar","year":"2021","journal-title":"J. Drug Target"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2004.07.001","article-title":"Model of transient drug diffusion across cornea","volume":"99","author":"Zhang","year":"2004","journal-title":"J. Control. Release"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Velpandian, T. (2016). Pharmacology of Ocular Therapeutics, Springer.","DOI":"10.1007\/978-3-319-25498-2"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1081\/DDC-120002997","article-title":"Penetration enhancers and ocular bioadhesives: Two new avenues for ophthalmic drug delivery","volume":"28","author":"Kaur","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4103\/2231-4040.85540","article-title":"Reduction in drop size of ophthalmic topical drop preparations and the impact of treatment","volume":"2","author":"Kumar","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2147\/OPTH.S118409","article-title":"Systemic side effects of eye drops: A pharmacokinetic perspective","volume":"10","author":"Farkouh","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijpharm.2018.11.016","article-title":"Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies","volume":"554","author":"Ranch","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Badran, M.M., Alomrani, A.H., Almomen, A., Bin Jardan, Y.A., and Abou El Ela, A.E.S. (2022). Novel Metoprolol-Loaded Chitosan-Coated Deformable Liposomes in Thermosensitive In Situ Gels for the Management of Glaucoma: A Repurposing Approach. Gels, 8.","DOI":"10.3390\/gels8100635"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Szalai, B., J\u00f3j\u00e1rt-Laczkovich, O., Kov\u00e1cs, A., Berk\u00f3, S., Balogh, G.T., Katona, G., and Budai-Sz\u0171cs, M. (2022). Design and Optimization of In Situ Gelling Mucoadhesive Eye Drops Containing Dexamethasone. Gels, 8.","DOI":"10.14232\/syrptbrs.2022.47"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.anai.2012.01.006","article-title":"Allergic conjunctivitis and dry eye syndrome","volume":"108","author":"Hom","year":"2012","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1080\/09273948.2020.1841804","article-title":"Allergy and Dry Eye Disease","volume":"29","author":"Leonardi","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/ACI.0000000000000471","article-title":"Ocular allergy as a risk factor for dry eye in adults and children","volume":"18","author":"Villani","year":"2018","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease","volume":"5","author":"Lemp","year":"2007","journal-title":"Ocul. Surf."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"Tfos dews ii pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtos.2017.10.001","article-title":"Neuropathic pain and dry eye","volume":"16","author":"Galor","year":"2018","journal-title":"Ocul. Surf."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1002\/jcp.24398","article-title":"The cellular mechanisms of dry eye: From pathogenesis to treatment","volume":"228","author":"Mantelli","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1517\/14656566.2013.802773","article-title":"Emerging therapies in allergic conjunctivitis and dry eye syndrome","volume":"14","author":"Nye","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Agarwal, P., Craig, J.P., and Rupenthal, I.D. (2021). Formulation considerations for the management of dry eye disease. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13020207"},{"key":"ref_55","unstructured":"Sheskey, P.J., Cook, W.G., and Cable, C.G. (2017). Handbook of Pharmaceutical Excipients, Pharmaceutical Press. [8th ed.]."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2147\/OPTH.S13773","article-title":"Systane lubricant eye drops in the management of ocular dryness","volume":"5","author":"Benelli","year":"2011","journal-title":"Clin. Ophthalmol."},{"key":"ref_57","unstructured":"Felton, L. (2012). Remington: The Science and Practice of Pharmacy, Pharmaceutical Press."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/ICO.0b013e318269cb99","article-title":"Choice of artificial tear formulation for patients with dry eye: Where do we start?","volume":"31","author":"Tong","year":"2012","journal-title":"Cornea"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"102112","DOI":"10.1016\/j.jddst.2020.102112","article-title":"Formulation of nanoparticles loaded in situ gel for treatment of dry eye disease: In vitro, ex vivo and in vivo evidences","volume":"61","author":"Laddha","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"111095","DOI":"10.1016\/j.msec.2020.111095","article-title":"Long-acting mucoadhesive thermogels for improving topical treatments of dry eye disease","volume":"115","author":"Luo","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"118979","DOI":"10.1016\/j.ijpharm.2019.118979","article-title":"Functional ibuprofen-loaded cationic nanoemulsion: Development and optimization for dry eye disease treatment","volume":"576","author":"Dukovski","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/all.13334","article-title":"Clinical implications of mast cell involvement in allergic conjunctivitis","volume":"73","author":"Rambasek","year":"2018","journal-title":"Allergy"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/bmj.38128.631319.AE","article-title":"Predicting bacterial cause in infectious conjunctivitis: Cohort study on informativeness of combinations of signs and symptoms","volume":"329","author":"Rietveld","year":"2004","journal-title":"Bmj"},{"key":"ref_64","first-page":"57","article-title":"The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca","volume":"3","author":"Gumus","year":"2009","journal-title":"Clin. Ophthalmol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.2147\/IJN.S173198","article-title":"Gelatin\u2013epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief","volume":"13","author":"Huang","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.colsurfb.2016.08.048","article-title":"Improving the topical ocular pharmacokinetics of an immunosuppressant agent with mucoadhesive nanoemulsions: Formulation development, in-vitro and in-vivo studies","volume":"148","author":"Akhter","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1021\/acs.molpharmaceut.6b00445","article-title":"Prolonged ocular retention of mucoadhesive nanoparticle eye drop formulation enables treatment of eye diseases using significantly reduced dosage","volume":"13","author":"Liu","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.carbpol.2016.03.079","article-title":"A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin","volume":"146","author":"Li","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Terreni, E., Chetoni, P., Tampucci, S., Burgalassi, S., Al-Kinani, A.A., Alany, R.G., and Monti, D. (2020). Assembling surfactants-mucoadhesive polymer nanomicelles (ASMP-nano) for ocular delivery of cyclosporine-A. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12030253"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.colsurfb.2016.01.014","article-title":"Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability","volume":"141","author":"Zeng","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.18240\/ijo.2020.09.05","article-title":"Crosslinked hyaluronic acid with liposomes and crocin for management symptoms of dry eye disease caused by moderate meibomian gland dysfunction","volume":"13","year":"2020","journal-title":"Int. J. Ophthalmol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"112255","DOI":"10.1016\/j.colsurfb.2021.112255","article-title":"Formulation and development of tacrolimus-gellan gum nanoformulation for treatment of dry eye disease","volume":"211","author":"Modi","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.actbio.2022.01.044","article-title":"Alleviation of dry eye syndrome with one dose of antioxidant, anti-inflammatory, and mucoadhesive lysine-carbonized nanogels","volume":"141","author":"Lin","year":"2022","journal-title":"Acta Biomater."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1208\/s12249-021-01957-4","article-title":"A New Approach for Dry Eye Management By Mucoadhesive In situ Gel of Vitamin B12: Formulation, In vitro and In vivo Assessment","volume":"22","author":"Mohamad","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"ref_75","unstructured":"Gra\u00e7a, A., Gon\u00e7alves, L.M., Raposo, S., Ribeiro, H.M., and Marto, J. (2019). Proceedings of the Iberian Meeting on Rheology, Springer International Publishing."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Eldesouky, L.M., El-Moslemany, R.M., Ramadan, A.A., Morsi, M.H., and Khalafallah, N.M. (2021). Cyclosporine lipid nanocapsules as thermoresponsive gel for dry eye management: Promising corneal mucoadhesion, biodistribution and preclinical efficacy in rabbits. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13030360"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Tampucci, S., Monti, D., Burgalassi, S., Terreni, E., Zucchetti, E., Baldacci, F., and Chetoni, P. (2018). Effect of 5-oxo-2-pyrrolidinecarboxylic acid (PCA) as a new topically applied agent for dry eye syndrome treatment. Pharmaceutics, 10.","DOI":"10.3390\/pharmaceutics10030137"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"110726","DOI":"10.1016\/j.msec.2020.110726","article-title":"Nanoscale poly (acrylic acid)-based hydrogels prepared via a green single-step approach for application as low-viscosity biomimetic fluid tears","volume":"110","author":"Swilem","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Lorenzo-Veiga, B., Diaz-Rodriguez, P., Alvarez-Lorenzo, C., Loftsson, T., and Sigurdsson, H.H. (2020). In vitro and ex vivo evaluation of Nepafenac-based cyclodextrin microparticles for treatment of eye inflammation. Nanomaterials, 10.","DOI":"10.3390\/nano10040709"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2021.06.011","article-title":"Ocular drug delivery to the anterior segment using nanocarriers: A mucoadhesive\/mucopenetrative perspective","volume":"336","author":"Dave","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1081\/DDC-120003445","article-title":"Ocular preparations: The formulation approach","volume":"28","author":"Kaur","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijpharm.2017.06.075","article-title":"Enhancement and inhibition effects on the corneal permeability of timolol maleate: Polymers, cyclodextrins and chelating agents","volume":"529","author":"Pastrana","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7569\/RAA.2014.097310","article-title":"Mucoadhesive Polymers for Enhancing Retention in Ocular Drug Delivery: A Critical Review","volume":"2","author":"Khare","year":"2014","journal-title":"Rev. Adhes. Adhes."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Dubashynskaya, N., Poshina, D., Raik, S., Urtti, A., and Skorik, Y.A. (2020). Polysaccharides in ocular drug delivery. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12010022"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.2042-7158.1996.tb05914.x","article-title":"Modified \u03b2-cyclodextrin (SBE7-\u03b2-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits","volume":"48","author":"Jarho","year":"1996","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2016.02.027","article-title":"In situ gelling systems based on Pluronic F127\/Pluronic F68 formulations for ocular drug delivery","volume":"502","author":"Ozhmukhametova","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/2230-973X.100042","article-title":"Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride","volume":"2","author":"Mandal","year":"2012","journal-title":"Int. J. Pharm. Investig."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.carbpol.2016.07.106","article-title":"Optimization of hyaluronan-based eye drop formulations","volume":"153","author":"Salzillo","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0939-6411(02)00036-X","article-title":"Optimisation of carbomer viscous eye drops: An in vitro experimental design approach using rheological techniques","volume":"54","author":"Ceulemans","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2147\/DDDT.S153405","article-title":"A novel ocular delivery of brinzolamide based on gellan gum: In vitro and in vivo evaluation","volume":"12","author":"Sun","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3109\/10717544.2014.920432","article-title":"Delivery of gatifloxacin using microemulsion as vehicle: Formulation, evaluation, transcorneal permeation and aqueous humor drug determination","volume":"23","author":"Kalam","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Yermak, I.M., Davydova, V.N., and Volod\u2019ko, A.V. (2022). Mucoadhesive Marine Polysaccharides. Mar. Drugs, 20.","DOI":"10.3390\/md20080522"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jddst.2018.10.020","article-title":"Potential of Chitosan and its derivatives for controlled drug release applications\u2013A review","volume":"49","author":"Safdar","year":"2019","journal-title":"J. Drug Deliv.Sci. Technol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Aranaz, I., Alcantara, A.R., Civera, M.C., Arias, C., Elorza, B., Heras Caballero, A., and Acosta, N. (2021). Chitosan: An Overview of Its Properties and Applications. Polymers, 13.","DOI":"10.3390\/polym13193256"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Gra\u00e7a, A., Gon\u00e7alves, L.M., Raposo, S., Ribeiro, H.M., and Marto, J. (2018). Useful in vitro techniques to evaluate the mucoadhesive properties of hyaluronic acid-based ocular delivery systems. Pharmaceutics, 10.","DOI":"10.3390\/pharmaceutics10030110"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Gupta, B., Mishra, V., Gharat, S., Momin, M., and Omri, A. (2021). Cellulosic Polymers for Enhancing Drug Bioavailability in Ocular Drug Delivery Systems. Pharmaceuticals, 14.","DOI":"10.3390\/ph14111201"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/jop.2016.0013","article-title":"Formulation and In Vitro Evaluation of Cyclosporine-A Inserts Prepared Using Hydroxypropyl Methylcellulose for Treating Dry Eye Disease","volume":"32","author":"Alzhrani","year":"2016","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/02713680490503787","article-title":"Pre-clinical investigation of the efficacy of an artificial tear solution containing hydroxypropyl-guar as a gelling agent","volume":"28","author":"Ubels","year":"2004","journal-title":"Curr. Eye Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/mabi.201000388","article-title":"Advances in mucoadhesion and mucoadhesive polymers","volume":"11","author":"Khutoryanskiy","year":"2011","journal-title":"Macromol. Biosci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jddst.2018.10.034","article-title":"Development of polysaccharide-based mucoadhesive ophthalmic lubricating vehicles: The effect of different polymers on physicochemical properties and functionality","volume":"49","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"106313","DOI":"10.1016\/j.ejps.2022.106313","article-title":"Betaine-modified hydroxyethyl cellulose (HEC): A biodegradable mucoadhesive polysaccharide exhibiting quaternary ammonium substructures","volume":"180","author":"Efiana","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Irimia, T., Dinu-P\u00eervu, C.-E., Ghica, M.V., Lupuleasa, D., Muntean, D.-L., Udeanu, D.I., and Popa, L. (2018). Chitosan-based in situ gels for ocular delivery of therapeutics: A state-of-the-art Review. Mar. Drugs, 16.","DOI":"10.3390\/md16100373"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.addr.2009.11.026","article-title":"Chitosan-based nanostructures: A delivery platform for ocular therapeutics","volume":"62","author":"Ravina","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_105","first-page":"204","article-title":"A review on chitin and chitosan polymers: Structure, chemistry, solubility, derivatives, and applications","volume":"2","author":"Zargar","year":"2015","journal-title":"Chem. Bio. Eng. Rev."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1517\/17425247.2012.690733","article-title":"Ocular drug delivery system: A reference to natural polymers","volume":"9","author":"Pahuja","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bioactmat.2020.04.013","article-title":"Drug-loaded chitosan film prepared via facile solution casting and air-drying of plain water-based chitosan solution for ocular drug delivery","volume":"5","author":"Li","year":"2020","journal-title":"Bioact. Mater."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejps.2017.12.012","article-title":"Drug transport mechanisms and in vitro release kinetics of vancomycin encapsulated chitosan-alginate polyelectrolyte microparticles as a controlled drug delivery system","volume":"114","author":"Unagolla","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"103763","DOI":"10.1016\/j.jddst.2022.103763","article-title":"Enhanced localization of cefazoline sodium in the ocular tissue using thermosensitive-mucoadhesive hydrogels: Formulation development, hemocompatibility and in vivo irritation studies","volume":"76","author":"Fiqri","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijpharm.2019.05.059","article-title":"Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma","volume":"566","author":"Tighsazzadeh","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/0975-7406.76478","article-title":"Mucoadhesive drug delivery systems","volume":"3","author":"Shaikh","year":"2011","journal-title":"J. Pharm. Bioallied. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.4155\/tde.14.75","article-title":"Advances in ophthalmic drug delivery","volume":"5","author":"Morrison","year":"2014","journal-title":"Ther. Deliv."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2010.05.031","article-title":"Synergistic interaction between TS-polysaccharide and hyaluronic acid: Implications in the formulation of eye drops","volume":"395","author":"Nazzi","year":"2010","journal-title":"Int. J. Pharm."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/10611860903450023","article-title":"Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: Development, characterization, and evaluation","volume":"18","author":"Wadhwa","year":"2010","journal-title":"J. Drug Target."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ejpb.2003.12.002","article-title":"Carrageenan\u2013gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: In vitro and preliminary in vivo studies","volume":"57","author":"Bonferoni","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejpb.2005.07.002","article-title":"Ophthalmic delivery systems based on drug\u2013polymer\u2013polymer ionic ternary interaction: In vitro and in vivo characterization","volume":"62","author":"Sandri","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_117","first-page":"595","article-title":"A randomized crossover study comparing trehalose\/hyaluronate eyedrops and standard treatment: Patient satisfaction in the treatment of dry eye syndrome","volume":"11","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/jop.2014.0164","article-title":"Effects of a hyaluronic acid\/hydroxypropyl guar artificial tear solution on protection, recovery, and lubricity in models of corneal epithelium","volume":"31","author":"Rangarajan","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijbiomac.2013.08.024","article-title":"Effect of xanthan gum and guar gum on in situ gelling ophthalmic drug delivery system based on poloxamer-407","volume":"62","author":"Bhowmik","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Moiseev, R.V., Morrison, P.W.J., Steele, F., and Khutoryanskiy, V.V. (2019). Penetration Enhancers in Ocular Drug Delivery. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11070321"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1517\/17425247.3.4.511","article-title":"Chemical modification and formulation approaches to elevated drug transport across cell membranes","volume":"3","author":"Majumdar","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejpb.2004.03.023","article-title":"Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs","volume":"58","author":"Verhoef","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1021\/bm0701550","article-title":"Interaction of chitosan with cell membrane models at the air\u2212 water interface","volume":"8","author":"Pavinatto","year":"2007","journal-title":"Biomacromolecules"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijfoodmicro.2004.01.022","article-title":"Chitosan kills bacteria through cell membrane damage","volume":"95","author":"Liu","year":"2004","journal-title":"Int. J. Food Microbiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1208\/ps040102","article-title":"Ocular tolerance of absorption enhancers in ophthalmic preparations","volume":"4","author":"Furrer","year":"2002","journal-title":"AAPS Pharm. Sci"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"861904","DOI":"10.1155\/2014\/861904","article-title":"Ophthalmic drug dosage forms: Characterisation and research methods","volume":"2014","author":"Baranowski","year":"2014","journal-title":"Sci. World J."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/03639045.2017.1294600","article-title":"A critical review about methodologies for the analysis of mucoadhesive properties of drug delivery systems","volume":"43","author":"Ferreira","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0168-3659(87)90004-6","article-title":"Bioadhesive analysis of controlled-release systems. I. Fracture and interpenetration analysis in poly (acrylic acid)-containing systems","volume":"5","author":"Ponchel","year":"1987","journal-title":"J. Control. Release"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.2042-7158.1984.tb04377.x","article-title":"An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery","volume":"36","author":"Smart","year":"1984","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijpharm.2014.10.035","article-title":"Corneal targeted nanoparticles for sustained natamycin delivery and their PK\/PD indices: An approach to reduce dose and dosing frequency","volume":"477","author":"Chandasana","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.ijbiomac.2014.10.014","article-title":"Amphotericin-B entrapped lecithin\/chitosan nanoparticles for prolonged ocular application","volume":"72","author":"Chhonker","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.addr.2005.07.008","article-title":"Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems","volume":"57","author":"Takeuchi","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40005-016-0233-4","article-title":"Quantitative evaluation of mucoadhesive polymers to compare the mucoadhesion","volume":"46","author":"Lee","year":"2016","journal-title":"J. Pharm. Investig."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1023\/A:1015812615635","article-title":"A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength","volume":"7","author":"Hassan","year":"1990","journal-title":"Pharm. Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpba.2018.04.041","article-title":"Rheological analysis and mucoadhesion: A 30 year-old and still active combination","volume":"156","author":"Rossi","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3109\/03639045.2015.1137306","article-title":"Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept","volume":"42","author":"Patel","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_137","first-page":"435","article-title":"Associations of natural polymers to modulate mucoadhesion of vaginal rinse-off and leave-on formulations","volume":"24","author":"Rossi","year":"2014","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_138","unstructured":"Mezger, T. (2014). The Rheology Handbook, Vincentz Network. [4th ed.]."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/03639045.2016.1238924","article-title":"Tear fluid-eye drops compatibility assessment using surface tension","volume":"43","author":"Hafner","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.exer.2003.09.019","article-title":"Functional aspects of the tear film lipid layer","volume":"78","author":"Bron","year":"2004","journal-title":"Exp. Eye Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/eye.1999.17","article-title":"Reliability of drop size from multi-dose eye drop bottles: Is it cause for concern?","volume":"13","author":"German","year":"1999","journal-title":"Eye"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1076\/ceyr.19.1.4.5341","article-title":"Components responsible for the surface tension of human tears","volume":"19","author":"Nagyova","year":"1999","journal-title":"Curr. Eye Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijbiomac.2016.04.070","article-title":"Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone","volume":"89","author":"Kalam","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ijpharm.2016.10.044","article-title":"Preformulation of cysteamine gels for treatment of the ophthalmic complications in cystinosis","volume":"515","author":"McKenzie","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejps.2018.12.012","article-title":"Corneal-PAMPA: A novel, non-cell-based assay for prediction of corneal drug permeability","volume":"128","author":"Vincze","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijpharm.2011.07.004","article-title":"Development of a serum-free human cornea construct for in vitro drug absorption studies: The influence of varying cultivation parameters on barrier characteristics","volume":"416","author":"Hahne","year":"2011","journal-title":"Int. J. Pharm."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1002\/jps.23190","article-title":"Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies","volume":"101","author":"Hahne","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"ref_148","first-page":"31","article-title":"Toward the practical implementation of eye-related bioavailability prediction models","volume":"19","author":"Reichl","year":"2014","journal-title":"Drug Discov."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s13346-015-0275-6","article-title":"In vitro and ex vivo corneal penetration and absorption models","volume":"6","author":"Agarwal","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0378-5173(02)00541-0","article-title":"The use of a porcine organotypic cornea construct for permeation studies from formulations containing befunolol hydrochloride","volume":"250","author":"Reichl","year":"2003","journal-title":"Int. J. Pharm."},{"key":"ref_151","first-page":"2942","article-title":"Culture model of human corneal epithelium for prediction of ocular drug absorption","volume":"42","author":"Toropainen","year":"2001","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0928-0987(03)00173-8","article-title":"Paracellular and passive transcellular permeability in immortalized human corneal epithelial cell culture model","volume":"20","author":"Toropainen","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/026119290803600106","article-title":"A comparative evaluation of corneal epithelial cell cultures for assessing ocular permeability","volume":"36","author":"Becker","year":"2008","journal-title":"Altern. Lab. Anim."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ejps.2021.105906","article-title":"Formulation of olopatadine hydrochloride viscous eye drops\u2013physicochemical, biopharmaceutical and efficacy assessment using in vitro and in vivo approaches","volume":"166","author":"Dukovski","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_155","unstructured":"Sunkara, G., and Kompella, U. (2003). Ophthalmic Drug Delivery Systems, Marcel Dekker, Inc."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/17425247.5.5.567","article-title":"Ocular novel drug delivery: Impacts of membranes and barriers","volume":"5","author":"Barar","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tox.2014.11.003","article-title":"An overview of current techniques for ocular toxicity testing","volume":"327","author":"Wilson","year":"2015","journal-title":"Toxicology"},{"key":"ref_158","first-page":"377","article-title":"Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes","volume":"82","author":"Draize","year":"1944","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_159","unstructured":"(2022, December 21). Eur-Lex. Available online: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=celex%3A32010L0063."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1167\/iovs.08-2992","article-title":"Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: Early detection of toxic damage","volume":"50","author":"Pauly","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fbioe.2020.00228","article-title":"Hydrogel biomaterials for application in ocular drug delivery","volume":"8","author":"Lynch","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0378-5173(99)00003-4","article-title":"Topical use of chitosan in ophthalmology: Tolerance assessment and evaluation of precorneal retention","volume":"180","author":"Felt","year":"1999","journal-title":"Int. J. Pharm."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.intimp.2003.10.013","article-title":"A chronic model for evaluating the itching associated with allergic conjunctivitis in rats","volume":"4","author":"Minami","year":"2004","journal-title":"Int. Immunopharmacol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3109\/10837450.2013.836217","article-title":"Design and characterization of chitosan-alginate microspheres for ocular delivery of azelastine","volume":"19","author":"Shinde","year":"2014","journal-title":"Pharm. Dev. Technol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1248\/bpb.23.566","article-title":"Experimental allergic conjunctivitis in guinea pigs induced by Japanese cedar pollen","volume":"23","author":"Takada","year":"2000","journal-title":"Biol. Pharm. Bull."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/s41591-018-0083-x","article-title":"Anatomical and functional dichotomy of ocular itch and pain","volume":"24","author":"Huang","year":"2018","journal-title":"Nat. Med."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1248\/bpb.26.1696","article-title":"Multiple cedar pollen challenge diminishes involvement of histamine in allergic conjunctivitis of Guinea pigs","volume":"26","author":"Fukushima","year":"2003","journal-title":"Biol. Pharm. Bull."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1515\/med-2017-0034","article-title":"Model for studying anti-allergic drugs for allergic conjunctivitis in animals","volume":"12","author":"Nakazawa","year":"2017","journal-title":"Open Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbi.2016.11.017","article-title":"Neuronal Fc-epsilon receptor I contributes to antigen-evoked pruritus in a murine model of ocular allergy","volume":"61","author":"Liu","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2005.09.004","article-title":"The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice","volume":"524","author":"Tamura","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1398-9995.2003.00326.x","article-title":"Animal models of allergic and inflammatory conjunctivitis","volume":"58","author":"Groneberg","year":"2003","journal-title":"Allergy"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1152\/jn.01139.2002","article-title":"Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens","volume":"89","author":"Schmelz","year":"2003","journal-title":"J. Neurophysiol."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/2\/470\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:19:23Z","timestamp":1760120363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/2\/470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":172,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["pharmaceutics15020470"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics15020470","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,31]]}}}